<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04602156</url>
  </required_header>
  <id_info>
    <org_study_id>EBD 515/16-9-2020</org_study_id>
    <nct_id>NCT04602156</nct_id>
  </id_info>
  <brief_title>US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy</brief_title>
  <acronym>TROSELCII</acronym>
  <official_title>Randomized Comparison of US-guided TROcar Versus SELdiger Technique for Percutaneous Cholecystostomy. The TROSELC II Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attikon Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Attikon Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center randomized comparison of bedside ultrasound (US)-guided trocar technique&#xD;
      versus the US-guided Seldinger technique for percutaneous cholecystostomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, randomized, controlled trial (RCT), comparing bedside US-guided&#xD;
      trocar technique versus the US-guided Seldinger technique for percutaneous cholecystostomy&#xD;
      (PC). The study will randomize a total of 100 consecutive patients (50 in each group)&#xD;
      undergoing PC at one large tertiary university hospital. The primary endpoints will be&#xD;
      technical success and procedure-related complication rates. Secondary endpoints will be&#xD;
      procedural duration, pain assessment, and clinical success after up to 3 months of follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">December 16, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 16, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical success</measure>
    <time_frame>At the end of the procedure</time_frame>
    <description>Image verified catheter placement within the gallbladder and subsequent bile aspiration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedure-related complications</measure>
    <time_frame>3 months</time_frame>
    <description>Minor or major complications attributed to the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of the procedure</measure>
    <time_frame>Intraprocedural</time_frame>
    <description>The time period between administration of local anesthesia and pigtail catheter positioning within the gallbladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraprocedural pain</measure>
    <time_frame>End of the procedure</time_frame>
    <description>pain experienced during the procedure assessed using a standard visual analogue score the procedure, as assessed using a standard visual analog score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-procedural pain</measure>
    <time_frame>12 hours</time_frame>
    <description>Pain experienced up to12 hours after procedure assessed using a standard visual analogue score (VAS - Visual Analog Scale 0-10, 0 representing no pain &amp; 10 representing worst pain experienced)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>72 hours</time_frame>
    <description>Gradual subsidence of signs, symptoms, and elevated inflammatory markers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cholecystitis</condition>
  <arm_group>
    <arm_group_label>Group T</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized to undergo PC catheter placement (8-French) using the trocar method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomized to undergo PC catheter placement (8-French) using the Sellinger method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trocar percutaneous cholecystostomy</intervention_name>
    <description>Percutaneous cholecystostomy using the one-step Trocar technique under US guidance. An 8Fr Trocar catheter will be inserted percutaneously within the gallbladder under real-time US guidance. The procedure will be performed using an aseptic technique, local anesthesia and intravenous opioid analgesia.</description>
    <arm_group_label>Group T</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Seldinger percutaneous cholecystostomy</intervention_name>
    <description>Percutaneous cholecystostomy using the Seldinger technique under US guidance. Following percutaneous puncture of the gallbladder with an 18G needle under real-time US guidance, an 8Fr catheter will be inserted percutaneously over the wire within the gallbladder under real-time US guidance. The procedure will be performed using an aseptic technique, local anesthesia and intravenous opioid analgesia.</description>
    <arm_group_label>Group S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients requiring PC, regardless of the underlying cause.&#xD;
&#xD;
          -  Signed informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years or &gt;100 years&#xD;
&#xD;
          -  The necessity for CT-guided PC catheter placement, according to the judgment of the&#xD;
             performing physician&#xD;
&#xD;
          -  Severe uncontrollable coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stavros Spiliopoulos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ATTIKO University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stavros Spiliopoulos</last_name>
    <phone>+302105831832</phone>
    <email>stavspiliop@med.uoa.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nikolaos Arkoudis</last_name>
    <phone>+302105831832</phone>
    <email>nick.arkoudis@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>&quot;Attikon&quot; University General Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <zip>12461</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stavros Spiliopoulos, MD, PhD,</last_name>
      <phone>6937403468</phone>
      <email>stavspiliop@med.uoa.gr</email>
    </contact>
    <contact_backup>
      <last_name>Nikolaos Arkoudis, MD</last_name>
      <phone>6983091554</phone>
      <email>nick.arkoudis@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attikon Hospital</investigator_affiliation>
    <investigator_full_name>Stavros Spiliopoulos</investigator_full_name>
    <investigator_title>Assistant Professor in Interventional Radiology</investigator_title>
  </responsible_party>
  <keyword>Percutaneous cholecystostomy</keyword>
  <keyword>ultrasound-guided</keyword>
  <keyword>interventional radiology</keyword>
  <keyword>Trocar</keyword>
  <keyword>Seldinger</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD could be available upon reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>IPD could be available after the completion of the study upon reasonable request</ipd_time_frame>
    <ipd_access_criteria>email</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

